Galtier-Dereure F, Capony F, Maudelonde T, Rochefort H
Unité Hormones et Cancer (U 148), INSERM, Montpellier, France.
J Clin Endocrinol Metab. 1992 Dec;75(6):1497-502. doi: 10.1210/jcem.75.6.1464654.
Ovarian cancers are highly invasive. In a first attempt to define the hormones and factors involved in the control of tumor invasion and metastasis, we have used the human ovarian cancer cell line BG-1 which contains both estrogen and progesterone receptors. Protein synthesis and secretion was assayed by [35S]methionine incorporation and polyacrylamide gel electrophoresis followed by fluorography. Three responses to estradiol were found: 1) procathepsin D secretion was increased, whereas the corresponding intracellular proteins were not significantly affected; 2) an abundant but nonidentified 120-kilodalton (kDa) estrogen-induced secreted glycoprotein, different from CA125, was detected for the first time; and 3) the number of cells as determined by DNA assay was markedly stimulated, reaching a higher level of confluency. The antiestrogen OH-tamoxifen was weakly agonist at low concentrations to stimulate cell growth but was a pure antagonist on the 120-kDa protein. The steroid specificity of these responses strongly suggests that they are mediated by the estrogen receptor. We conclude that cathepsin D secretion is specifically stimulated by estrogen in this ovarian cancer cell line as it is in estrogen receptor-positive breast cancer cells. Both cathepsin D and a newly described 120-kDa secreted glycoprotein are potential markers of hormone responsiveness and/or aggressiveness which deserve to be further studied in clinical ovarian cancers.
卵巢癌具有高度侵袭性。为了首次确定参与控制肿瘤侵袭和转移的激素及因子,我们使用了同时含有雌激素和孕激素受体的人卵巢癌细胞系BG-1。通过[35S]甲硫氨酸掺入法和聚丙烯酰胺凝胶电泳随后进行荧光显影来检测蛋白质合成和分泌。发现了对雌二醇的三种反应:1)组织蛋白酶D原分泌增加,而相应的细胞内蛋白质未受到显著影响;2)首次检测到一种丰富但未鉴定的120千道尔顿(kDa)雌激素诱导分泌糖蛋白,不同于CA125;3)通过DNA检测确定的细胞数量受到显著刺激,达到更高的汇合水平。抗雌激素OH-他莫昔芬在低浓度时是弱激动剂以刺激细胞生长,但对120-kDa蛋白是纯拮抗剂。这些反应的类固醇特异性强烈表明它们是由雌激素受体介导的。我们得出结论,在这种卵巢癌细胞系中,组织蛋白酶D分泌像在雌激素受体阳性乳腺癌细胞中一样受到雌激素的特异性刺激。组织蛋白酶D和一种新描述的120-kDa分泌糖蛋白都是激素反应性和/或侵袭性的潜在标志物,值得在临床卵巢癌中进一步研究。